Timing and Dose of Statin Therapy Define Its Impact on Inflammatory and Endothelial Responses During Myocardial Infarction
Author(s) -
Andrei C. Spósito,
Simone Nascimento dos Santos,
Eliana Cotta de Faria,
Dulcinéia Saes Parra Abdalla,
Luiza P. da Silva,
Alexandre A. Sousa Soares,
André V.T. Japiassú,
José C. Quinaglia e Silva,
José Antônio Franchini Ramires,
Otávio Rizzi Coelho
Publication year - 2011
Publication title -
arteriosclerosis thrombosis and vascular biology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.007
H-Index - 270
eISSN - 1524-4636
pISSN - 1079-5642
DOI - 10.1161/atvbaha.110.218685
Subject(s) - simvastatin , medicine , statin , myocardial infarction , tumor necrosis factor alpha , brachial artery , cardiology , gastroenterology , c reactive protein , endocrinology , inflammation , blood pressure
Clinical trials of statins during myocardial infarction (MI) have differed in their therapeutic regimes and generated conflicting results. This study evaluated the role of the timing and potency of statin therapy on its potential mechanisms of benefit during MI.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom